China Botanic Pharma Revenue, Profits - CBPI Annual Income Statement

Add to My Stocks
$0 $0 (0%) CBPI stock closing price Jun 14, 2018 (Closing)

CBPI stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the China Botanic Pharma stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the CBPI stock is bound to reflect the impact of the YOY growth of 31.77%. The China Botanic Pharma profit and loss statement for 2011 shows a net profit of $25.91M. Profits for last year was $17.86M. Apart from this an investor should also check China Botanic Pharma assets and China Botanic Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Nov - Oct2011201020092008
China Botanic Pharma Revenues or Net Sales
72.71M55.18M43.41M36.16M
Cost Of Goods Sold (COGS)29.53M25.76M20.31M15.98M
China Botanic Pharma Gross Profit
43.18M29.41M23.1M20.18M
Research & Development Expense3.59M3.04M2.52M2.12M
Selling General & Admin Expense10.07M8.58M5.76M6.18M
Income Before Depreciation Depletion Amortization29.52M17.79M14.8M11.87M
Depreciation Depletion Amortization----
Non Operating Income----
Interest Expense----
China Botanic Pharma Pretax Income
29.64M17.86M14.84M11.98M
Provision for Income Taxes3.72M---
MinorityInterest----
Investment Gains Losses----
Other Income----
Income Before Extraordinaries & Disc Operations25.91M17.86M14.84M11.98M
Extraordinary Items & Discontinued Operations----
China Botanic Pharma Profit/ Loss (Net Income)
25.91M17.86M14.84M11.98M
Average Shares used to compute Diluted EPS37.68M40.18M--
Average Shares used to compute Basic EPS37.24M37.24M--
Income Before Nonrecurring Items25.92M17.87M--
Income from Nonrecurring Items----
China Botanic Pharma Earnings Per Share Basic Net
0.700.48--
China Botanic Pharma Earnings Per Share Diluted Net
0.690.44--
EPS Diluted Before Nonrecurring Items0.690.44--
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common0.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

It is very helpful to read a report on China Botanic Pharma stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the China Botanic Pharma revenue chart, as is the case with China Botanic Pharma indicates a growing business. One needs to compare the YoY topline or sales growth of CBPI stock with its peers like GBIM stock and CHME stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like China Botanic Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The CBPI financials along with China Botanic Pharma historical stock prices provide a lot of details about the firm.